Odiparcil (Standard)

Overview

Odiparcil (Standard) is the analytical standard of Odiparcil ( HY-10277 ). This product is intended for research and analytical applications. Odiparcil (SB-424323) is an orally active β-D-xyloside derivative. Odiparcil can effectively divert the synthesis of cellular glycosaminoglycans (GAG) into secreted soluble species and reduce GAG accumulation. Odiparcil shows antithrombin and antiplatelet activity. Odiparcil can be used for the researches of metabolic and cardiovascular disease , such as mucopolysaccharidoses (MPS) and thrombosis.

Application

Products | Products > Signaling Pathways > Others | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Metabolic Disease | Products > Research Areas > Cardiovascular Disease | Products > Signaling Pathways > Reference Standards | Products > Signaling Pathways > Thrombin

Product Information

• Catalog No.: HY-10277R
• CAS No.: 137215-12-4
• Molecular Formula: C15H16O6S
• Molecular Weight: 324.35
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source